Hospital-acquired and ventilator-associated pneumonia: Clinical sciences

Last updated: April 02, 2023

Hospital-acquired and ventilator-associated pneumonia: Clinical sciences

ISU PA Program Prep for PACKRAT Exam

ISU PA Program Prep for PACKRAT Exam

Non-urothelial bladder cancers
Pyelonephritis: Clinical sciences
Renal failure: Pathology review
Transitional cell carcinoma
Physical and sexual abuse
Bulimia nervosa
Opioid intoxication and overdose: Clinical sciences
Post-traumatic stress disorder
Tobacco use disorder
Tobacco use: Clinical sciences
Psoriatic arthritis: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Anatomy clinical correlates: Hip, gluteal region and thigh
Back pain: Pathology review
Developmental dysplasia of the hip: Clinical sciences
Gout: Clinical sciences
Osteomyelitis: Clinical sciences
Osteoporosis: Clinical sciences
Sciatica
Septic arthritis: Clinical sciences
Bordetella pertussis (Whooping cough)
Cellulitis and erysipelas: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
HIV (AIDS)
Infectious gastroenteritis: Clinical sciences
Lyme disease: Clinical sciences
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Acute leukemia
Approach to anemia (destruction and sequestration): Clinical sciences
Autoimmune hemolytic anemia
Hemochromatosis: Clinical sciences
Pernicious anemia: Year of the Zebra
Sickle cell disease: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Celiac disease
Choledocholithiasis and cholangitis: Clinical sciences
Colorectal cancer screening: Clinical sciences
Colorectal cancer: Clinical sciences
Peptic ulcer disease: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Diabetic ketoacidosis: Clinical sciences
Hyperparathyroidism: Clinical sciences
Thyroid carcinoma: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Angina pectoris
Aortic dissection: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to hypertension: Clinical sciences
Ventricular tachycardia: Clinical sciences
Atrial fibrillation
Cardiomyopathies: Pathology review
Congestive heart failure: Clinical sciences
Coronary artery disease: Clinical sciences
Essential hypertension: Clinical sciences
Infectious endocarditis: Clinical sciences
Marfan syndrome
Mitral valve disease
Myocardial infarction
Pericarditis: Clinical sciences
Tricuspid valve disease
Buerger disease: Year of the Zebra
Vasculitis: Clinical
Aspiration pneumonia and pneumonitis: Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Approach to a cough (acute): Clinical sciences
Asthma: Clinical sciences
Community-acquired pneumonia: Clinical sciences
COVID-19: Clinical sciences
Deep vein thrombosis and pulmonary embolism: Pathology review
HIV and AIDS: Pathology review
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Hypersensitivity pneumonitis
Klebsiella pneumoniae
Pneumonia
Pneumonia: Pathology review
Pulmonary edema
Pulmonary embolism: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Tuberculosis (pulmonary): Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Pneumonia is a lung infection that results in inflammation of one or both lungs. Most often, it is caused by bacteria like Streptococcus pneumoniae; or viruses, such as influenza; but rarely, pneumonia can be caused by fungi as well.

Now, based on the setting in which pneumonia develops, we can subdivide it into two main types: community-acquired pneumonia, or CAP for short, which is when a person develops pneumonia outside of a hospital or within 48 hours after hospital admission; and hospital-acquired pneumonia, or HAP, which develops after 48 hours from hospital admission. Finally, there’s a special subtype of HAP called ventilator-acquired pneumonia, or VAP, which refers to pneumonia that occurs in patients on mechanical ventilation, 48 hours after endotracheal intubation.

Now, when a patient presents with signs and symptoms suggestive of HAP or VAP, the first step is to obtain a focused history and physical examination and order labs such as CBC and procalcitonin. You should also use pulse oximetry to check oxygen saturation levels, and collect a blood sample for cultures. Finally, don’t forget to obtain imaging, such as chest x-ray or point-of-care lung ultrasound.

Alright, first, let’s talk about the diagnosis and acute management of patients with HAP. Let's start with History. These patients usually report a fever, productive cough, pleuritic chest pain, and shortness of breath. Keep in mind that these symptoms develop at least 48 hours after admission. Now, the physical examination typically reveals elevated temperature, tachypnea, and tachycardia, as well as rales, and decreased breath sounds. When it comes to labs, they are likely to show elevated WBC count and procalcitonin levels, while pulse oximetry can reveal a drop in oxygen saturation. Finally, a chest X-ray usually reveals a new lung infiltrate, consolidation, or effusion.

Now, if a patient presents with these findings, you can diagnose HAP and start acute management. This means that you need to provide continuous monitoring of the heart rate, blood pressure, and oxygen saturation. Also, if needed, be sure to provide supplemental oxygen to keep the oxygen saturation above 92%. The next step is to find the causative organism through microbiological testing. This involves collecting sputum samples, usually by sputum induction. To do this, the patient should first inhale a saline mist, which will trigger a reflexive cough to release sputum from the lower airways. Sputum samples are then sent to the laboratory for gram staining and cultures. Additionally, if you suspect MRSA infection, sputum and nasopharyngeal swab samples can be sent for multiplex PCR studies.

Alright, let’s switch gears and talk about the diagnosis and acute management of patients with VAP. Patients with suspected VAP are typically sedated and intubated, so you won’t be able to get the history from them. So, discuss with other hospital staff and look through the medical chart for information like the time of intubation or a history of purulent secretions. The physical examination usually reveals signs like fever, tachycardia, rales, and decreased breath sounds. Keep in mind that these signs develop 48 hours after intubation.

Similarly to HAP, labs usually show elevated WBCs and procalcitonin, while oxygen saturation might be low. However, unlike HAP, the imaging of choice for VAP is a point-of-care lung ultrasound because it’s ideal for patients who can’t be easily transported. Common findings include subpleural consolidation, liver-like echogenicity of the lung, and dynamic air bronchograms.

Okay, if a patient presents with these findings, you can diagnose VAP, and you should start acute management immediately. Just like before, you will need to provide continuous monitoring of their heart rate, blood pressure, and oxygen saturation. Additionally, be sure to regularly assess ventilatory parameters and adjust the ventilator settings to maximize oxygenation.

Once the acute management is started, your next step is to look for the causative organism through microbiological testing. Remember that patients with VAP are intubated, therefore the induced sputum technique is not possible. Alternative techniques to collect sputum include bronchoalveolar lavage, or BAL for short, and mini-BAL. In BAL, a bronchoscope is inserted through the trachea into the lungs to reach a terminal segment of the affected lung lobe, inject sterile saline, and then suction a sample. On the other hand, in mini-BAL, a telescoping catheter is inserted through the endotracheal tube into the lower airways to obtain a sample. Regardless of the collection technique, you will send the sputum samples to the laboratory for gram staining, cultures, and possibly multiplex PCR studies if MRSA is suspected.

Sources

  1. "Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society" Clin Infect Dis (2016)
  2. "International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT)" Eur Respir J (2017)
  3. "Trends in Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia Trials" Clin Infect Dis (2021)
  4. "New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia" Semin Respir Crit Care Med (2022)
  5. "Non-ventilator associated hospital acquired pneumonia incidence and health outcomes among U.S. veterans from 2016-2020" Am J Infect Control (2022)
  6. "Nutritional risk screening score as an independent predictor of nonventilator hospital-acquired pneumonia: a cohort study of 67,280 patients" BMC Infect Dis (2021)
  7. "Microbiological data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score" Intensive Care Med (2010)
  8. "Community-acquired Pneumonia and Hospital-acquired Pneumonia" Med Clin North Am (2019)
  9. "Incidence and mortality of hospital-acquired bacteraemia: a population-based cohort study applying a multi-state model approach" Clin Microbiol Infect (2022)
  10. "Nonventilator hospital-acquired pneumonia: A call to action" Infect Control Hosp Epidemiol (2021)
  11. "Bronchoalveolar Lavage" StatPearls Publishing (2022)
  12. "The Lung Microbiome and Pneumonia" J Infect Dis (2021)
  13. "Pneumonia" Nat Rev Dis Primers (2021)